UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 852

Sortiert nach

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies

Vox sanguinis, 2003-01, Vol.84 (1), p.45-53

2003

Volltextzugriff (PDF)

PHASE I STUDY OF PATUPILONE PLUS CARBOPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.40-40

2004

Volltextzugriff (PDF)

Parameters of Care for Craniosynostosis

The Cleft palate-craniofacial journal, 2012-01, Vol.49 (1_suppl), p.1-24

2012

Volltextzugriff (PDF)

Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3335-3344

1998

Volltextzugriff (PDF)

Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors

Experimental hematology, 1993-11, Vol.21 (12), p.1583

1993

Volltextzugriff (PDF)

Interleukin-3 In Vivo: Kinetic of Response of Target Cells

Blood, 1993-10, Vol.82 (7), p.2054-2061

1993

Volltextzugriff (PDF)

Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy

Annals of oncology, 1993-11, Vol.4 (9), p.759-766

1993

Volltextzugriff (PDF)

Spontaneous hypoglycemia associated with autoimmunity specific to human insulin

Diabetes care, 1987-03, Vol.10 (2), p.152

1987

Volltextzugriff (PDF)

Mobilization of peripheral blood stem cells with chemotherapy and cytokines in multiple myeloma

Stem cells (Dayton, Ohio), 1995-08, Vol.13 Suppl 2, p.148

1995

Volltextzugriff (PDF)

Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma

Oncology, 1993-11, Vol.50 (6), p.466

1993

Volltextzugriff (PDF)

Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets

The Journal of infectious diseases, 1986-02, Vol.153 (2), p.315

1986

Volltextzugriff (PDF)

Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrhea management: A phase I multicenter trial

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3593-3593

2006

Volltextzugriff (PDF)

Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer (ACC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.3688-3688

2005

Volltextzugriff (PDF)

Phase I trial of patupilone plus carboplatin in patients with advanced cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.5087-5087

2005

Volltextzugriff (PDF)

Phase I/II dose escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7110-7110

2005

Volltextzugriff (PDF)

P-546 Phase I/II trial of patupilone once every 3 weeks in patients with non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S261-S261

2005

Volltextzugriff (PDF)

A phase I/II dose-escalation trial of EPO906 every 3 weeks in patients with relapsed/refractory ovarian, primary fallopian, or primary peritoneal cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5102-5102

2004

Volltextzugriff (PDF)

A phase I/II dose-escalation trial of EPO906 every 3 weeks in patients with relapsed/refractory ovarian, primary fallopian, or primary peritoneal cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5102-5102

2004

Volltextzugriff (PDF)

Association of specific immune response to pork and beef insulin with certain HLA-DR antigens in type 1 diabetes

British medical journal (Clinical research ed.), 1982-11, Vol.285 (6353), p.1451

1982

Volltextzugriff (PDF)

iNEXT: a European facility network to stimulate translational structural biology

FEBS letters, 2018-06, Vol.592 (12), p.1909-1917

2018

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, Administered on a Daily-times-five every-three-week Schedule in Patients with Advanced Solid Malignancies

Clinical cancer research, 2002-07, Vol.8 (7), p.2157-2166

2002

Volltextzugriff (PDF)

Evaluation of accessory cell heterogeneity III. role of dendritic cells in the in vitro activation of the antibody response to soluble antigens

Immunobiology (1979), 1985-05, Vol.169 (4), p.424-435

1985

Volltextzugriff (PDF)

One-dose and multiple-dose kinetics of minocycline in patients with renal disease

Agents and Actions, 1977-09, Vol.7 (3), p.369-377

1977

Volltextzugriff (PDF)

Analysis of the in vitro induction of insulin-specific helper T cells

Basic and clinical aspects of immunity to insulin, 2019, p.31-44

Originally published 1981, 2019

Volltextzugriff (PDF)

Phase III efficacy study of interleukin‐3 after autologous bone marrow transplantation in patients with malignant lymphoma

British journal of haematology, 1999-09, Vol.106 (3), p.730-736

1999

Volltextzugriff (PDF)

1 – 25 von 852

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(744)
Mit Volltextzugriff
(774)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(391)
Life Sciences & Biomedicine
(271)
Physical Sciences
(117)
Physics
(101)
Biochemistry & Molecular Biology
(94)
Humans
(86)
Biological And Medical Sciences
(78)
Technology
(71)
Models, Molecular
(50)
Animals
(46)
Plant Sciences
(45)
Nucleic Acid Conformation
(43)
Biophysics
(42)
Fundamental And Applied Biological Sciences. Psychology
(42)
Female
(40)
Proteins
(39)
Chemistry
(38)
Medical Sciences
(37)
Physics, Applied
(37)
Life Sciences
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies

PHASE I STUDY OF PATUPILONE PLUS CARBOPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES

Parameters of Care for Craniosynostosis

Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma

Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors

Interleukin-3 In Vivo: Kinetic of Response of Target Cells

Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy

Spontaneous hypoglycemia associated with autoimmunity specific to human insulin

Mobilization of peripheral blood stem cells with chemotherapy and cytokines in multiple myeloma

Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma

Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets

Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrhea management: A phase I multicenter trial

Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer (ACC)

Phase I trial of patupilone plus carboplatin in patients with advanced cancer

Phase I/II dose escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer

P-546 Phase I/II trial of patupilone once every 3 weeks in patients with non-small cell lung cancer (NSCLC)

A phase I/II dose-escalation trial of EPO906 every 3 weeks in patients with relapsed/refractory ovarian, primary fallopian, or primary peritoneal cancer

A phase I/II dose-escalation trial of EPO906 every 3 weeks in patients with relapsed/refractory ovarian, primary fallopian, or primary peritoneal cancer

Association of specific immune response to pork and beef insulin with certain HLA-DR antigens in type 1 diabetes

iNEXT: a European facility network to stimulate translational structural biology

A Phase I and Pharmacokinetic Study of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, Administered on a Daily-times-five every-three-week Schedule in Patients with Advanced Solid Malignancies

Evaluation of accessory cell heterogeneity III. role of dendritic cells in the in vitro activation of the antibody response to soluble antigens

One-dose and multiple-dose kinetics of minocycline in patients with renal disease

Analysis of the in vitro induction of insulin-specific helper T cells

Phase III efficacy study of interleukin‐3 after autologous bone marrow transplantation in patients with malignant lymphoma

Suchergebnisse filtern